Comparison of fluorescence in situ hybridization and dual colour chromogenic in situ hybridization for the assessment of HER2 status on gastric cancer biopsies

被引：0
|
作者：
Gomez-Martin, C. [1 ]
Garcia-Garcia, E. [2 ]
Suarez-Gauthier, A. [2 ]
Conde, E. [2 ]
Lopez-Rios, F. [2 ]
机构：
[1] 12 Octubre Univ Hosp, Div Med Oncol, Madrid, Spain
[2] Hosp Madrid Norte, Lab Dianas Terapeut, Madrid, Spain
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71373-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：404 / 404
页数：1
相关论文
共 50 条
  • [1] Comparison of fluorescence in situ hybridization and dual color chromogenic in situ hybridization for the assessment of HER2 status on core-needle breast cancer biopsies
    Suarez-Gauthier, A.
    Garcia-Garcia, E.
    Conde, E.
    Munoz, A.
    Torres, M.
    Miro, C.
    Garcia-Estevez, L.
    Lopez-Rios, F.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 209S - 209S
  • [2] The correlation between dual colour chromogenic in situ hybridization and fluorescence in situ hybridization in assessing HER2 gene status
    Pedersen, Marianne
    Rasmussen, Birgitte Bruun
    [J]. APMIS, 2008, 116 (03) : 250 - 250
  • [3] HER2 status in breast carcinomas: comparison between silver in situ hybridization, chromogenic in situ hybridization and fluorescence in situ hybridization
    Ali, S. A. Md
    Nurhayati, H. M.
    Munirah, M. A.
    Reena, M. Z.
    Masir, N.
    Chandramaya, S. F.
    Rohaizak, M.
    Asmiati, A.
    Sharifah, N. A.
    Rafie, M. K.
    [J]. EJC SUPPLEMENTS, 2010, 8 (05): : 185 - 185
  • [4] Comparison of dual-colour chromogenic in-situ hybridization and fluorescence in-situ hybridization in the assessment of HER2 gene amplification in breast carcinoma
    Conlon, Susan
    Colgan, Aoife
    Allen, David
    O'Grady, Anthony
    Kay, Elaine W.
    [J]. HISTOPATHOLOGY, 2011, 58 (02) : 320 - 321
  • [5] Chromogenic in situ hybridization for Her-2/neu-oncogene in breast cancer: comparison of a new dual-colour chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization
    Mayr, Doris
    Heim, Sibylle
    Weyrauch, Kerstin
    Zeindl-Eberhart, Evelyn
    Kunz, Anne
    Engel, Jutta
    Kirchner, Thomas
    [J]. HISTOPATHOLOGY, 2009, 55 (06) : 716 - 723
  • [6] Comparison of fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH) for assessment of HER2 gene amplification in breast cancer
    Bhargava, R
    Lal, P
    Salazar, PA
    Chen, B
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2004, 6 (02): : 151 - 151
  • [7] Dual-colour chromogenic in-situ hybridization is a potential alternative to fluorescence in-situ hybridization in HER2 testing
    Hwang, Cheng-Cheng
    Pintye, Mariann
    Chang, Liang-Che
    Chen, Huang-Yang
    Yeh, Kun-Yan
    Chein, Hui-Ping
    Lee, Nin
    Chen, Jim-Ray
    [J]. HISTOPATHOLOGY, 2011, 59 (05) : 984 - 992
  • [8] HER2 status in invasive breast cancer: Immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization
    Shirsat, Hemlata S.
    Epari, Sridhar
    Shet, Tanuja
    Bagal, Rajani
    Hawaldar, Rohini
    Desai, Sangeeta B.
    [J]. INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (02) : 175 - 179
  • [9] Her2 amplification - Correlation of chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization
    Wixom, CR
    Albers, EA
    Weidner, N
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2004, 12 (03) : 248 - 251
  • [10] Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization for Low and High Throughput HER2 Genetic Testing
    Poulsen, Tim S.
    Espersen, Maiken L. M.
    Kofoed, Vibeke
    Dabetic, Tanja
    Hogdall, Estrid
    Balslev, Eva
    [J]. INTERNATIONAL JOURNAL OF BREAST CANCER, 2013, 2013
12345